AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $91.1 million versus the consensus estimate of $90.74 million.

GUIDANCE:

AngioDynamics sees FY2024 EPS of $0.28-$0.34, versus the consensus of ($0.08). AngioDynamics sees FY2024 revenue of $328-333 million, versus the consensus of $323 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.